Prostate Adaptive Radiation Therapy

Prostate ART is a two phase study looking at using adaptive radiotherapy to help reduce toxicity for prostate cancer patients. Adaptive radiotherapy is a new technology that provides the ability to account for daily changes in anatomy. Adaptive radiotherapy also provides a foundation for which radiotherapy margins might be safely reduced. Phase 1 of this study is looking to see if a radiation therapist centred adaptive workflow can be implemented. If phase 1 of this study is safe and feasible, the study will proceed to phase 2. Part 2 of the study looks at using adaptive technology to reduc

Trial Details

NCT ID
NCT06547398
Phase
NA
Sponsor
Royal North Shore Hospital
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Adaptive radiotherapy +/- Margin Reduction
  • Image guided radiotherapy
Locations (sample)
  • St Leonards, New South Wales, Australia|-33.82344,151.19836

Key Eligibility Criteria

  • \- Age \> 18
  • Biopsy proven prostate malignancy
  • Definitive treatment is radiotherapy to the prostate alone
  • ECOG performance status 0-2

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →